<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

World

Dexamethasone isn't a coronavirus breakthrough

19 June 2020

8:07 PM

19 June 2020

8:07 PM

It’s welcome news, of course, that dexamethasone can reduce mortality in people with moderate to severe respiratory complications due to Covid-19. But to hail it as a big breakthrough – as the Health Secretary Matt Hancock did this week – is a step too far. Perhaps next week, Hancock will be shouting about the use of paracetamol as a treatment for headaches.

Already a subscriber? Log in

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

Already a subscriber? Log in

Close